{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:26:04Z","timestamp":1794320764505,"version":"4.9.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ijbiomac.2025.146888","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T23:26:26Z","timestamp":1755127586000},"page":"146888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["Targeting FGFR2 with natural products: Discovery and experimental validation of torosanin as a potent and selective therapeutic candidate for gallbladder cancer"],"prefix":"10.1016","volume":"322","author":[{"given":"Qingyun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Suleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denggang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.146888_bb0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.36347\/sasjs.2024.v10i09.001","article-title":"Gallbladder carcinoma: a review of literature","volume":"9","author":"Kulshrestha","year":"2024","journal-title":"SAS J Surg"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0010","first-page":"99","article-title":"Gallbladder cancer: epidemiology and outcome","author":"Hundal","year":"2014","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0015","series-title":"A Review of Recent Data in the Treatment of Gallbladder cancer: What we Know, What we Do, and What Should Be Done","first-page":"e165","volume":"vol. 34","author":"M\u00fcller","year":"2014"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0020","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.dld.2025.02.007","article-title":"Global burden of gallbladder cancer in 2022 and predictions to 2042","volume":"57","author":"Guo","year":"2025","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0025","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1470-2045(03)01021-0","article-title":"Carcinoma of the gallbladder","volume":"4","author":"Misra","year":"2003","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0040","first-page":"349","article-title":"Epidemiology and molecular pathology of gallbladder cancer","volume":"51","author":"Lazcano-Ponce","year":"2001","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0045","series-title":"Development of Lipid-Based Nanoparticles for Combination Treatment of Pancreatic Cancer With Hyperthermia","author":"Aparicio-Lopez","year":"2024"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0050","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.27777","article-title":"Risk factors for gallbladder cancer: a case\u2013control study","volume":"132","author":"Jain","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146888_bb0055","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"22","key":"10.1016\/j.ijbiomac.2025.146888_bb0060","doi-asserted-by":"crossref","first-page":"D165","DOI":"10.2741\/Klint","article-title":"Signal transduction by fibroblast growth factor receptors","volume":"4","author":"Klint","year":"1999","journal-title":"Front. Biosci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nm0603-661","article-title":"Endothelial signaling during development","volume":"9","author":"Cleaver","year":"2003","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0070","doi-asserted-by":"crossref","first-page":"19439","DOI":"10.1038\/s41598-024-69850-1","article-title":"Structure-based drug-development study against fibroblast growth factor receptor 2: molecular docking and molecular dynamics simulation approaches","volume":"14","author":"Shamsi","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146888_bb0080","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1021\/bi0352320","article-title":"Kinetic model for FGF, FGFR, and proteoglycan signal transduction complex assembly","volume":"43","author":"Ibrahimi","year":"2004","journal-title":"Biochemistry"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146888_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115383","article-title":"Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications","volume":"9","author":"Churi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146888_bb0090","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2159-8290.CD-20-0766","article-title":"Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib","volume":"11","author":"Silverman","year":"2021","journal-title":"Cancer Discov."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146888_bb0095","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1007\/s00432-022-04428-w","article-title":"Sustained response on sequential anti-FGFR therapy in metastatic gall bladder cancer: a case report and literature review","volume":"149","author":"Sheth","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146888_bb0100","article-title":"Fgfr signaling and endocrine resistance in breast cancer: challenges for the clinical development of FGFR inhibitors","volume":"1876","author":"Servetto","year":"2021","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146888_bb0105","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1158\/2159-8290.CD-22-1441","article-title":"Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer","volume":"13","author":"Facchinetti","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119671","article-title":"Wu-Mei-wan promotes ferroptosis in gallbladder cancer through STAT3 negative regulation: an integrated HPLC, proteomics, network pharmacology, and experimental validation study","volume":"347","author":"Zhao","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146888_bb0115","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s00210-023-02551-0","article-title":"The anti-tumoral role of hesperidin and aprepitant on prostate cancer cells through redox modifications","volume":"396","author":"Akbari","year":"2023","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073389","article-title":"Ultrasound-assisted synthesis of substituted chalcone-linked 1, 2, 3-triazole derivatives as antiproliferative agents: in vitro antitumor activity and molecular docking studies","volume":"26","author":"C\u00e1ceres","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146888_bb0125","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1080\/07391102.2023.2272186","article-title":"Interaction between the antioxidant compound safranal and \u03b1-chymotrypsin in spectroscopic fields and molecular modeling approaches","volume":"42","author":"Zohreh Vahedi","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.146888_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10111850","article-title":"Designing of peptide based multi-epitope vaccine construct against gallbladder cancer using immunoinformatics and computational approaches","volume":"10","author":"Dar","year":"2022","journal-title":"Vaccines"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0135","doi-asserted-by":"crossref","first-page":"11568","DOI":"10.1038\/s41598-025-96707-y","article-title":"Enhancing the anticancer effects of rosmarinic acid in PC3 and LNCaP prostate cancer cells using titanium oxide and selenium-doped graphene oxide nanoparticles","volume":"15","author":"Hosseinzadeh Ranjbar","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s11101-019-09606-2","article-title":"The landscape of natural product diversity and their pharmacological relevance from a focus on the dictionary of natural products\u00ae","volume":"18","author":"Chassagne","year":"2019","journal-title":"Phytochem. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0145","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/1570178618666210707161025","article-title":"The importance of flavonoids and phytochemicals of medicinal plants with antiviral activities","volume":"19","author":"Shahrajabian","year":"2022","journal-title":"Mini-Rev. Org. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-021-03423-x","article-title":"Potential antiviral effects of some native Iranian medicinal plants extracts and fractions against influenza A virus","volume":"21","author":"Mehrbod","year":"2021","journal-title":"BMC Complement. Med. Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146888_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115453","article-title":"Structure-based drug design of 1, 3, 5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2","volume":"28","author":"Kuriwaki","year":"2020","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067536","article-title":"Towards ligand docking including explicit interface water molecules","volume":"8","author":"Lemmon","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113390","article-title":"Structure-based drug design of an inhibitor of the SARS-CoV-2 (COVID-19) main protease using free software: a tutorial for students and scientists","volume":"218","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1202128","article-title":"Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)","volume":"14","author":"Sayaf","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146888_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004586","article-title":"AutoDockFR: advances in protein-ligand docking with explicitly specified binding site flexibility","volume":"11","author":"Ravindranath","year":"2015","journal-title":"PLoS Comput. Biol."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146888_bb0180","doi-asserted-by":"crossref","first-page":"7318","DOI":"10.1039\/D2RA00277A","article-title":"Blocking key mutated hotspot residues in the RBD of the omicron variant (B. 1.1. 529) with medicinal compounds to disrupt the RBD-hACE2 complex using molecular screening and simulation approaches","volume":"12","author":"Khan","year":"2022","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0185","doi-asserted-by":"crossref","first-page":"9.12. 1","DOI":"10.1002\/0471141755.ph0912s49","article-title":"Overview on the rule of five","volume":"49","author":"Pollastri","year":"2010","journal-title":"Curr. Protoc. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0190","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6446(01)01712-3","article-title":"Screening for human ADME\/Tox drug properties in drug discovery","volume":"6","author":"Li","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0200","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"PkCSM, predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146888_bb0205","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.146888_bb0210","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"WIREs Comput. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0215","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jcc.540090611","article-title":"A stable, rapidly converging conjugate gradient method for energy minimization","volume":"9","author":"Watowich","year":"1988","journal-title":"J. Comput. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0220","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/wics.117","article-title":"Steepest descent","volume":"2","author":"Meza","year":"2010","journal-title":"Wiley Interdisciplinary Reviews: Computational Statistics"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0225","series-title":"Computational Approaches in Physics","article-title":"Atomistic methods","author":"Fyta","year":"2016"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146888_bb0230","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0235","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146888_bb0240","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0245","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221142793","article-title":"Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: molecular docking and molecular dynamics simulation studies","volume":"36","author":"Azeem","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.146888_bb0250","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.4155\/fmc-2018-0314","article-title":"Deep learning and virtual drug screening","volume":"10","author":"Carpenter","year":"2018","journal-title":"Future Med. Chem."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.146888_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061375","article-title":"A review on applications of computational methods in drug screening and design","volume":"25","author":"Lin","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.146888_bb0260","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1021\/acs.jnatprod.7b00283","article-title":"NANPDB: a resource for natural products from northern African sources","volume":"80","author":"Ntie-Kang","year":"2017","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0265","first-page":"1","article-title":"SANCDB: a south African natural compound database","volume":"7","author":"Hatherley","year":"2015","journal-title":"Aust. J. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.146888_bb0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0275","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/s13065-024-01347-4","article-title":"Molecular exploration of natural and synthetic compounds databases for promising hypoxia inducible factor (HIF) Prolyl-4-hydroxylase domain (PHD) inhibitors using molecular simulation and free energy calculations","volume":"18","author":"Sayaf","year":"2024","journal-title":"BMC chemistry"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100458","article-title":"Identifying potential inhibitors of phosphatidylinositol 4, 5-bisphosphate 3-kinase: molecular dynamic insights into the interaction and inhibitory mechanism","volume":"8","author":"Mohammad","year":"2024","journal-title":"Chemical Physics Impact"},{"issue":"14","key":"10.1016\/j.ijbiomac.2025.146888_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411671","article-title":"MD\u2013ligand\u2013receptor: a high-performance computing tool for characterizing ligand\u2013receptor binding interactions in molecular dynamics trajectories","volume":"24","author":"Pieroni","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0290","doi-asserted-by":"crossref","first-page":"14123","DOI":"10.1038\/s41598-024-61439-y","article-title":"Identification of potential modulators for human GPD1 by docking-based virtual screening, molecular dynamics simulations, binding free energy calculations, and DeLA-drug analysis","volume":"14","author":"Hu","year":"2024","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031771","article-title":"Molecular docking and molecular dynamics simulations discover curcumin analogue as a plausible dual inhibitor for SARS-CoV-2","volume":"23","author":"Rampogu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.146888_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/biom14121521","article-title":"Natural compounds targeting thymic stromal Lymphopoietin (TSLP): a promising therapeutic strategy for atopic dermatitis","volume":"14","author":"Suleman","year":"2024","journal-title":"Biomolecules"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.146888_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.sjbs.2023.103753","article-title":"Molecular dynamics and simulation analysis against superoxide dismutase (SOD) target of Micrococcus luteus with secondary metabolites from bacillus licheniformis recognized by genome mining approach","volume":"30","author":"Bagewadi","year":"2023","journal-title":"Saudi Journal of Biological Sciences"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.146888_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e11232","article-title":"Molecular modeling, molecular dynamics simulation, and essential dynamics analysis of grancalcin: an upregulated biomarker in experimental autoimmune encephalomyelitis mice","volume":"8","author":"Paul","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.146888_bb0315","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13065-024-01185-4","article-title":"Abrogation of ORF8\u2013IRF3 binding interface with carbon nanotube derivatives to rescue the host immune system against SARS-CoV-2 by using molecular screening and simulation approaches","volume":"18","author":"Suleman","year":"2024","journal-title":"BMC chemistry"},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1328308","article-title":"Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations","volume":"14","author":"Suleman","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"48","key":"10.1016\/j.ijbiomac.2025.146888_bb0325","doi-asserted-by":"crossref","first-page":"32938","DOI":"10.1021\/acsomega.1c04996","article-title":"Prediction of binding free energy of protein\u2013ligand complexes with a hybrid molecular mechanics\/generalized born surface area and machine learning method","volume":"6","author":"Dong","year":"2021","journal-title":"ACS Omega"},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.146888_bb0330","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ijbiomac.2025.146888_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2025.102697","article-title":"Exploring global natural product databases for NLRP3 inhibition: unveiling novel combinatorial therapeutic strategy for hidradenitis Suppurativa","volume":"18","author":"Suleman","year":"2025","journal-title":"J. Infect. Public Health"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146888_bb0340","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41416-022-01908-1","article-title":"Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing","volume":"127","author":"Neumann","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.146888_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107265","article-title":"FGFR-mediated ERK1\/2 signaling contributes to mesendoderm and definitive endoderm formation in vitro","volume":"26","author":"Lau","year":"2023","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.146888_bb0350","doi-asserted-by":"crossref","first-page":"e367","DOI":"10.1002\/mco2.367","article-title":"FGFR families: biological functions and therapeutic interventions in tumors","volume":"4","author":"Liu","year":"2020","journal-title":"MedComm"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.146888_bb0355","doi-asserted-by":"crossref","DOI":"10.3390\/cells10030659","article-title":"Signaling pathways in Cancer: therapeutic targets, combinatorial treatments, and new developments","volume":"10","author":"Yip","year":"2021","journal-title":"Cells"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025074458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025074458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T17:16:17Z","timestamp":1757006177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025074458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":71,"alternative-id":["S0141813025074458"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146888","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting FGFR2 with natural products: Discovery and experimental validation of torosanin as a potent and selective therapeutic candidate for gallbladder cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146888","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"146888"}}